NORFOVET INJECTION
Product Details
Advancing Veterinary Care with High-Potency Norfloxacin Therapy
Targeted DNA Gyrase Inhibition: Norfovet works by inhibiting the enzyme DNA gyrase (topoisomerase II), effectively halting bacterial DNA replication and transcription.
Immediate Bactericidal Action: Unlike bacteriostatic agents that only slow growth, Norfovet is rapidly bactericidal. Pathogens begin to lose viability within 20 to 30 minutes of administration, significantly shortening recovery times.
Broad-Spectrum Efficacy: It offers comprehensive protection against a wide range of Gram-positive and Gram-negative bacteria, including E. coli, Salmonella, Staphylococcus spp., and Mycoplasma.
1. Excellence in Mastitis & Metritis Management
Norfovet is highly effective in treating udder and reproductive tract infections. It crosses the blood-milk barrier efficiently, providing high clearance in infected udders and ensuring the health of dairy herds.
2. Advanced Respiratory and Urinary Support
The formulation is designed to concentrate in the lungs and kidneys. This makes it a first-line defense for pneumonia, bronchitis, and complex urinary tract infections like pyelonephritis, where standard treatments might fail.
3. Stability in Challenging Environments
Many antibiotics lose efficacy in acidic environments. However, Norfovet maintains its potency even at acidic infection sites, ensuring consistent performance in inflamed tissues or infected urine.
Achieving Peak Performance: Dosage and Safety
Norfovet is formulated for convenience and safety, offering a flexible administration route (IM or IV) to suit the clinical needs of the animal. With low protein binding, the "free drug" concentration remains high, allowing for a sustained therapeutic effect for 4–8 hours post-injection.
